Simplify Asset Management Inc. Eye Point Pharmaceuticals, Inc. Transaction History
Simplify Asset Management Inc.
- $1.77 Billion
- Q3 2025
A detailed history of Simplify Asset Management Inc. transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Simplify Asset Management Inc. holds 90,440 shares of EYPT stock, worth $1.1 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
90,440
Previous 79,472
13.8%
Holding current value
$1.1 Million
Previous $747,000
67.47%
% of portfolio
0.07%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding EYPT
# of Institutions
160Shares Held
67.1MCall Options Held
214KPut Options Held
994K-
Cormorant Asset Management, LP Boston, MA8.33MShares$101 Million7.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.8MShares$82.5 Million2.2% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.8MShares$82.4 Million0.11% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.6MShares$55.7 Million0.09% of portfolio
-
Franklin Resources Inc San Mateo, CA4.3MShares$52.1 Million0.01% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $413M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...